Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease (NCT05970367) | Clinical Trial Compass
CompletedNot Applicable
Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease
Belgium102 participantsStarted 2023-07-10
Plain-language summary
This project will consist of 1 large clinical trial with 3 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs and benefits; (3) process evaluation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures;
β. A diagnosis of central neurological disease, made by a specialist. Conditions may include stroke or spinal cord injury:
β. Stroke: Participants must have received a diagnosis of stroke for the first time, have been diagnosed at least 3 months ago, and live at home.
β. SCI: Participants have a rating A, B, C or D on the American Spinal Injury Association (ASIA) measurement scale, which refers to patients with complete or incomplete impairment. All levels of SCI can be included, if there is a clear patient need linked to the upper and/or lower extremities.
β. At least 3 months post discharge from hospital/rehabilitation centre, living at home;
β. Having a maximum recovery of 85% of independence in daily functioning (FIM/SCIM);
β. Had a normal functional state prior to the pathology: a pre-pathology Barthel Index \> 85/100;
β. Unilateral or bilateral weakness of the affected upper or lower limbs (No maximum score in all affected limbs = motricity index: score 5 on 3/3 segments)
Exclusion criteria
β. Having other neurological or musculoskeletal conditions that may affect the protocol, assessed by a specialist;
β. No ability to initiate movements against gravity in the upper and lower limbs;
. Severe visual impairment, communication, cognitive and language formation problems that would prevent the intervention and measurement process, assessed by a specialist;
β. Any disorder, which in the investigator's opinion might the compromise participant's safety or compliance with the CIP;